Work

In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2.

Year: 1994

Type: article

Source: PubMed

Authors: T Kalebic, M Tsokos, L J Helman

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: Growth Hormone and Insulin-like Growth Factors

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2104135564

FWCI: 8.496

Cites: 8

Cited by: 187

Related to: 10